Dermal integration of hyaluronic acid fllers: observation in real clinical practice
https://doi.org/10.33667/2078-5631-2022-8-107-111
Abstract
A clinical observation of the dermal integration of low-concentration products based on hyaluronic acid produced by KPM and IPN-Like technologies is presented. KPM technology is a method of obtaining a cohesive poly-compacted gel matrix of hyaluronic acid, which determines the peculiarity of distribution in the skin due to particles of different densities in one product. On the one hand, the drug remains at the injection site after injection due to dense particles, on the other hand, translocation of loose particles into a more modifed part of the dermis. The clinical effect is manifested in the form of full integration of the drug into the dermis, imitating natural volumes. IPN-Like technology involves the preparation of a hyaluronic acid preparation from two monophase chains with low and high elasticity. Interpenetrating stabilized chains are obtained under pressure. Partial independence of IPN structures is necessary for the predicted integration and distribution of the drug in tissues, whereas the increased density of cross-linking nodes strengthens the intensity of the chemical bond, strengthens the fxation of the drug at the injection site. The study was conducted on seven patients using ultrasound scanning before the procedure, during the procedure to control the introduction into the required layer, 15 minutes after the procedure and 2 months later. To objectify the data, skin proflometry was used and photodocumentation in the designated time frame. In the presented clinical case, when comparing the distribution of fllers based on hyaluronic acid, it was revealed that all drugs are well distributed in the surface layers of the dermis, which makes it possible to safely inject drugs created using IPN-Like technology in the same techniques and to the same depth as the drug with CPM technology. According to ultrasound of the skin, drugs produced by IPN-Like technology showed greater effectiveness in terms of dermis thickness after 2 months.
About the Authors
J. Yu. Yusova
Central State Medical Academy
Russian Federation
Russian Federation
Yusova Zhanna Yu., DM Sci Ihabil.), dermatovenerologist, cosmetologist, physiotherapist, prof. at Dept of Dermatovenereology and Cosmetology
E. L. Baranova
Central State Medical Academy
Russian Federation
Russian Federation
Baranova Elena L., dermatologist, cosmetologist, physiotherapist, candidate for PhD Med degree at Dept of Physical and Rehabilitation Medicine with a course of clinical psychology and pedagogy
D. V. Demidion
Central State Medical Academy
Russian Federation
Russian Federation
Demidion Diana V., dermatologist, cosmetologist, physiotherapist, candidate for PhD Med degree at Dept of Physical and Rehabilitation Medicine with a course of clinical psychology and pedagogy
I. A. Akhmedbaeva
Central State Medical Academy
Russian Federation
Russian Federation
Akhmedbaeva Inga A., dermatologist, cosmetologist, physiotherapist, candidate for PhD Med degree at Dept of Physical and Rehabilitation Medicine with a course of clinical psychology and pedagogy
L. S. Kruglova
Central State Medical Academy
Russian Federation
Russian Federation
Kruglova Larisa S., DM Sci (habil.), professor, vice-rector for academic affairs, head of Dept of Dermatovenereology and Cosmetology
SPIN: 1107–4372
References
1. Plastic Surgery Key (2016). Avilable at: https://plasticsurgerykey.com/standard-evaluation-of-thepatient-the-merz-scale (accessed 01 March 2018).
2. Talarico S., Hassun K. M., Monteiro E. O., Parada M.O.B., Bu- ratini L.B., Arruda L., Bagatin E. Safety and efficacy evalu- ation of a new hyaluronic acid-based fller in the treatment of nasolabial folds and lips outline. Cosmet. Dermatol. 2010; 2 (2): 83–6. Available at: http://sinclair-college.com/wp-content/uploads/2018/01/safety-and-efficacy-evaluation-of-a-new-hyaluronic-acid-based-fller.pdf (accessed 01 March 2018).
3. Kulichova D., Borovaya A., Ruzicka, Thomas P., Gauglitz G. G. Understanding the safety and tolerability of facial filling therapeutics. Expert. Opin. Drug. Saf. 2014; 13 (9): 1215–26. DOI: 10.1517/14740338.2014.939168.
4. Edelev D.A., Glazko V., Izmailov I.V. Clinical manifestations of cases delayed immune response after the introduction of fllers based on hyaluronic acid. Injection techniques in cosmetology. Russian Journal (Inektsionnye metody v kosmetologii). 2014; (2): 147–51 (in Russian).
5. Costa Modern injection plastic face: edge or something more? Injection techniques in cosmetology. Russian Journal (Inektsionnye metody v kosmetologii). 2015; (3): 48–60 (in Russian).
6. De Boulle K., Glogau R., Kono, Nathan M., Tezel A., Roca- Martinez J.X., Paliwal S., Stroumpoulis D. A review of the metabolism of 1,4-butanediol diglycidyl ether-crosslinked hyaluronic acid dermal fllers. Dermatol. Surg. 2013; 39 (12): 1758–66.
7. Gubanova Е. I., Starovatova A., Rodina M. Yu. 12-months effects of stabilized hyaluronic acid gel compared with saline for rejuvenation of aging hands. J. Drugs Dermatol. 2015; 14 (3): 288–98.
8. Karpova I., Karlyshev V.A. Contour injection plasty of soft tissues. The system optimization. Moscow: BINOM; 2016 (in Russian).
9. Privalova E.G., Gubanova E.I., Vasiliev Yu., Davydov D.V. Role of ultrasound high resolution in the diagnosis of complications contouring the face. Metamorphosis. Russian Journal (Metamorfozy). 2017; (18): 28–33 (in Russian).
Review
For citations:
Yusova J.Yu., Baranova E.L., Demidion D.V., Akhmedbaeva I.A., Kruglova L.S. Dermal integration of hyaluronic acid fllers: observation in real clinical practice. Medical alphabet. 2022;(8):107-111. (In Russ.) https://doi.org/10.33667/2078-5631-2022-8-107-111
Views:
315
Email this article 